Effects of parkinsonism on health status in welding exposed workers

Parkinsonism and Related Disorders

Volumn 17, Issue 9, 2011, Pages 672-676

  Harris, Rachel C ^a   Lundin, Jessica I ^b   Criswell, Susan R ^a,c   Hobson, Angela ^a   Swisher, Laura M ^a,c   Evanoff, Bradley A ^a   Checkoway, Harvey ^b   Racette, Brad A ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c American Parkinson Disease Association Advanced Center for Parkinson Research   (United States)

Author keywords

Health status; Parkinson disease; Parkinsonism; Quality of life; Welding

Indexed keywords

ADULT; ARTICLE; BRADYKINESIA; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DYSGRAPHIA; EMOTION; FAMILY HISTORY; FEMALE; FUME; GAIT DISORDER; HEALTH STATUS; HISPANIC; HUMAN; INTOXICATION; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NEUROLOGIC DISEASE; OCCUPATIONAL SAFETY; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE 39; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY ANALYSIS; STIGMA; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; WELDING; WELLBEING;

FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PARKINSONIAN DISORDERS; PREVALENCE; QUALITY OF LIFE; WELDING;

EID: 80054872160     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.05.021     Document Type: Article

References (30)

1. Alcalay R.N., Caccappolo E., Mejia-Santana H., Tang M.X., Rosado L., Ross B.M., et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol 2010, 9:1116-1122.
2. Klein C., Schneider S.A., Lang A.E. Hereditary parkinsonism: Parkinson disease look-alikes-an algorithm for clinicians to "PARK" genes and beyond. Mov Disord 2009, 14:2042-2058.
3. Kamel F., Tanner C., Umbach D., Hoppin J., Alavanja M., Blair A., et al. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol 2007, 4:364-374.
4. Willis A.W., Evanoff B.A., Lian M., Galarza A., Wegrzyn A., Schootman M., et al. Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems. Am J Epidemiol 2010, 12:1357-1363.
5. Fryzek J.P., Hansen J., Cohen S., Bonde J.P., Llambias M.T., Kolstad H.A., et al. A cohort study of Parkinson's disease and other neurodegenerative disorders in Danish welders. J Occup Environ Med 2005, 5:466-472.
6. Racette B.A., Tabbal S.D., Jennings D., Good L., Perlmutter J.S., Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 2005, 2:230-235.
7. Household Data: annual averages: employed persons by detailed occupation, sex, race, and Hispanic or Latino ethnicity 2008, Bureau of Labor Statistics, U.S. Department of Labor, Bureau of Labor Statistics, Washington, DC.
8. Rodier J. Manganese poisoning in Moroccan miners. Brit J Industr Med 1955, 12:21-35.
9. Chandra S.V., Shukla G.S., Srivastava R.S., Singh H., Gupta V.P. An exploratory study of manganese exposure to welders. Clin Toxicol 1981, 4:407-416.
10. Den Oudsten B.L., Van Heck G.L., De V.J. Quality of life and related concepts in Parkinson's disease: a systematic review. Mov Disord 2007, 11:1528-1537.
11. Orley J., Saxena S., Herrman H. Quality of life and mental illness. Reflections from the perspective of the WHOQOL. Br J Psychiatry 1998, 172:291-293.
12. Jenkinson C., Peto V., Fitzpatrick R., Greenhall R., Hyman N. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing 1995, 6:505-509.
13. Peto V., Jenkinson C., Fitzpatrick R., Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995, 3:241-248.
14. Harrison J.E., Preston S., Blunt S.B. Measuring symptom change in patients with Parkinson's disease. Age Ageing 2000, 1:41-45.
15. Hobson A.J., Sterling D.A., Emo B., Evanoff B.A., Sterling C.S., Good L., et al. Validity and reliability of an occupational exposure questionnaire for parkinsonism in welders. J Occup Environ Hyg 2009, 6:324-331.
16. Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007, 7:990-997.
17. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002, 8:732-738.
18. Fahn S., Elton R.L. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease 1987, 153-163. Macmillan, New York. S. Fahn, C.D. Marsden, M. Goldstein, D.B. Calne (Eds.).
19. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 2007, 15:1480-1490. Parkinson Study Group.
20. Tanner C.M., Gilley D.W., Goetz C.G. A brief screening questionnaire for parkinsonism. Ann Neurol 1990, 28:267-268.
21. Schrag A., Jahanshahi M., Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000, 6:1112-1118.
22. Duarte J., Claveria L.E., de Pedro-Cuesta J., Sempere A.P., Coria F., Calne D.B. Screening Parkinson's disease: a validated questionnaire of high specificity and sensitivity. Mov Disord 1995, 5:643-649.
23. Louis E.D., Tang M.X., Schupf N., Mayeux R. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol 2005, 2:297-302.
24. Roels H., Lauwerys R., Buchet J.P., Genet P., Sarhan M.J., Hanotiau I., et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med 1987, 3:307-327.
25. Wennberg A., Iregren A., Struwe G., Cizinsky G., Hagman M., Johansson L. Manganese exposure in steel smelters a health hazard to the nervous system. Scand J Work Environ Health 1991, 4:255-262.
26. Mergler D., Huel G., Bowler R., Iregren A., Belanger S., Baldwin M., et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res 1994, 2:151-180.
27. Kim H.C., Park S.G., Min K.B., Yoon K.J. Depressive symptoms and self-reported occupational injury in small and medium-sized companies. Int Arch Occup Environ Health 2009, 6:715-721.
28. Bhattacherjee A., Chau N., Sierra C.O., Legras B., Benamghar L., Michaely J.P., et al. Relationships of job and some individual characteristics to occupational injuries in employed people: a community-based study. J Occup Health 2003, 6:382-391.
29. Hagell P., Whalley D., McKenna S.P., Lindvall O. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord 2003, 7:773-783.
30. Bowler R.M., Roels H.A., Nakagawa S., Drezgic M., Diamond E., Park R., et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 2007, 3:167-177.